NCT00791154 2024-08-23
SCLC
NantCell, Inc.
Phase 1/2 Terminated
Clinical Trials
7 trialsNCT00788957 2024-08-07
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
NantBioScience, Inc.
Phase 1/2 Completed
NCT02137343 2016-04-04
RILOMET-2
Amgen
Phase 3 Terminated
NCT01791374 2016-02-29
Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ
Amgen
Phase 1 Completed
NCT01697072 2016-02-09
RILOMET-1
Amgen
Phase 3 Terminated
NCT00770848 2014-03-10
AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer
Amgen
Phase 1/2 Completed
NCT00719550 2013-12-05
AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
Amgen
Phase 1/2 Completed